BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17482832)

  • 1. Adverse reactions to contrast media: an analysis from spontaneous reporting data.
    Cutroneo P; Polimeni G; Curcuruto R; Calapai G; Caputi AP
    Pharmacol Res; 2007 Jul; 56(1):35-41. PubMed ID: 17482832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.
    Kalaiselvan V; Sharma S; Singh GN
    Drug Saf; 2014 Sep; 37(9):703-10. PubMed ID: 25085041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database.
    An J; Jung H; Kwon OY; Kang Y; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Allergy Clin Immunol Pract; 2019; 7(7):2205-2211. PubMed ID: 30877072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department.
    García M; Aguirre U; Martinez A; Ruiz B; Lertxundi U; Aguirre C
    Br J Radiol; 2014 Jan; 87(1033):20130511. PubMed ID: 24191124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance.
    Sessa M; Rossi C; Mascolo A; Grassi E; Fiorentino S; Scavone C; Reginelli A; Rotondo A; Sportiello L
    Expert Opin Drug Saf; 2015; 14(9):1341-51. PubMed ID: 26156557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging.
    Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A
    J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany.
    Sachs B; Fischer-Barth W; Merk HF
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1076-84. PubMed ID: 26285651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography.
    Kim SR; Lee JH; Park KH; Park HJ; Park JW
    Clin Exp Allergy; 2017 Jan; 47(1):106-112. PubMed ID: 27648932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy).
    Cutroneo P; Greco S; Cucinotta G; Arcoraci V; Caputi AP
    Pharmacol Res; 1999 Jul; 40(1):41-6. PubMed ID: 10378989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate reactions to iodinated contrast media.
    Morales-Cabeza C; Roa-Medellín D; Torrado I; De Barrio M; Fernández-Álvarez C; Montes-Aceñero JF; De La Riva I; Prieto-García A
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):553-557. PubMed ID: 29017901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system.
    Kim MH; Park CH; Kim DI; Kim KM; Kim HK; Lim KH; Song WJ; Lee SM; Kim SH; Kwon HS; Park HW; Yoon CJ; Cho SH; Min KU; Kim YY; Chang YS
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):167-71. PubMed ID: 22374199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrinsic warming of low-osmolality iodinated contrast media to 37°C reduced the rate of allergic-like reaction.
    Zhang B; Liu J; Dong Y; Guo B; Lian Z; Yu H; Luo X; Mo X; Zhang L; Huang W; Ouyang F; Li X; Liang C; Zhang S
    Allergy Asthma Proc; 2018 Nov; 39(6):e55-e63. PubMed ID: 30401329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.